Synthesis of new series of thiazol-(2(3H)-ylideneamino)benzenesulfonamide derivatives as carbonic anhydrase inhibitors
dc.authorid | Ergun, Adem/0000-0003-4647-6058 | |
dc.authorid | Gencer, Nahit/0000-0001-7092-8857 | |
dc.authorid | ARSLAN, Mustafa/0000-0003-0796-4374 | |
dc.authorid | Berber, Nurcan/0000-0002-1595-585X | |
dc.contributor.author | Berber, Nurcan | |
dc.contributor.author | Arslan, Mustafa | |
dc.contributor.author | Vural, Firat | |
dc.contributor.author | Ergun, Adem | |
dc.contributor.author | Gencer, Nahit | |
dc.contributor.author | Arslan, Oktay | |
dc.date.accessioned | 2025-01-27T21:01:47Z | |
dc.date.available | 2025-01-27T21:01:47Z | |
dc.date.issued | 2020 | |
dc.department | Çanakkale Onsekiz Mart Üniversitesi | |
dc.description.abstract | Human carbonic anhydrase I and II isoenzymes (hCA I and II) are important metabolic enzymes. In this study, a new series of thiazol-(2(3H)-ylideneamino)benzenesulfonamide derivatives were synthesized and also some inhibition parameters including IC50(hydratese) and inhibition constant values (K-i, esterase) were determined. All studied compounds exhibited potent inhibition against these enzymes. They inhibited carbonic anhydrases (CAs) with the IC(50)values of 113 to 395.8 nM (K-i = 77.38-319.59 nM) for hCA I and 91.9 to 516 nM (K-i = 62.79-425.89 nM) for hCA II. Among the compounds,5cwas found to be the most active one (K-i: 77.38 nM) for hCA I and5gwas found for hCA II with the value of 62.79 nM. | |
dc.description.sponsorship | Research Fund of the Balikesir universitesi Scientific Research Projects Unit (TURKEY) [2017/166] | |
dc.description.sponsorship | This study was supported by the Research Fund of the Balikesir universitesi Scientific Research Projects Unit (TURKEY) (2017/166). | |
dc.identifier.doi | 10.1002/jbt.22596 | |
dc.identifier.issn | 1095-6670 | |
dc.identifier.issn | 1099-0461 | |
dc.identifier.issue | 12 | |
dc.identifier.pmid | 32762006 | |
dc.identifier.scopus | 2-s2.0-85089026922 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.uri | https://doi.org/10.1002/jbt.22596 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12428/27189 | |
dc.identifier.volume | 34 | |
dc.identifier.wos | WOS:000556034700001 | |
dc.identifier.wosquality | Q2 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Wiley | |
dc.relation.ispartof | Journal of Biochemical and Molecular Toxicology | |
dc.relation.publicationcategory | info:eu-repo/semantics/openAccess | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.snmz | KA_WoS_20250125 | |
dc.subject | 2-iminothiazoline | |
dc.subject | carbonic anhydrase | |
dc.subject | enzyme inhibitor | |
dc.subject | sulfonamide | |
dc.title | Synthesis of new series of thiazol-(2(3H)-ylideneamino)benzenesulfonamide derivatives as carbonic anhydrase inhibitors | |
dc.type | Article |